Illumina (ILMN) Cash & Equivalents (2009 - 2026)

Illumina has reported Cash & Equivalents for 18 years, with the latest figure at $1.0 billion in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $1.0 billion, up 11.35% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.0 billion (up 11.35% YoY), and the FY2025 annual result was $1.4 billion, up 25.82% from the prior year.
• Cash & Equivalents fell to $1.0 billion in Q2 2026, from $1.1 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $2.0 billion in Q1 2023 and troughed at $869.0 million in Q3 2024.
• A 5-year average of $1.2 billion and a median of $1.1 billion in 2024 frame the typical range for Cash & Equivalents.
• The widest annual swing landed in 2022, when Cash & Equivalents plunged 69.52%; it then surged 63.23% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $1.0 billion in 2022, then climbed by 4.8% to $1.0 billion in 2023, then grew by 7.54% to $1.1 billion in 2024, then advanced by 25.82% to $1.4 billion in 2025, then decreased by 26.66% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $1.0 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.4 billion in Q4 2025.